Healthcare

March 16, 2023

University of Nebraska Medical Center and ANANDA Scientific announce First Patient Enrolled in FDA-approved clinical trial for Post-Traumatic Stress Disorder (PTSD)

The University of Nebraska Medical Center (UNMC) and ANANDA Scientific Inc. today announced that the first patient has been enrolled in an FDA-approved clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary Liquid Structure™ delivery technology, for Post-Traumatic Stress Disorder (PTSD). (Clinical Trials.gov Identifier NCT05269459) The trial is being led by principal investigator Matthew Rizzo, MD, FAAN, FANA, the Reynolds Professor and Chair of the UNMC Department of Neurological Sciences, chief physician for neurological services at Nebraska Medicine, and chief physician......

March 16, 2023

Innovation in Resistance Management: VECTRONTM T500, a New Vector Control Product, is Prequalified by the World Health Organization (WHO)

VECTRONTM T500 is a new IRS product containing TENEBENALTM, the world’s first meta-diamide active ingredient (IRAC Group 30) developed by Mitsui Chemicals Agro which has a different mode of action from existing vector control products.

VECTRONTM"...

March 14, 2023

Forbes Features Three Moroccans Among MENA’s Top 100 Healthcare Leaders 2023

Rabat - Forbes Middle East has unveiled its annual list of the Middle East and North Africa (MENA) region’s “Top 100 Healthcare Leaders 2023,” celebrating the region’s “most influential healthcare heads” across several areas.

The"...

March 13, 2023

Region’s first Global Robotic MedTech Forum to reveal latest advancements in robotic surgery

The US Society of Robotic Surgery and Crescent Healthcare (a Division of the Crescent Group of Companies) host the first Global Robotic MedTech Forum in the Middle East on 16 March 2023 in Dubai. The event, the first dedicated global forum to gather world renowned experts in the region,"...

March 9, 2023

Morocco Continues to Suffer Acute Shortage of Health Workers

Rabat - The number of health workers in Morocco is disproportionately low compared to the overall size of the population, the country’s Court of Audits laments in a new report.

As of the end of 2021, the"...

March 7, 2023

New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients

Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey and colleagues at institutions in Bathinda and Pondicherry, India evaluated the use of noninvasive, continuous Masimo PVi®, as part of goal-directed fluid therapy (GDFT), to guide intraoperative fluid administration during neurosurgery – the first study to evaluate PVi in this surgical scenario – by comparing it to a parameter obtained invasively, stroke volume variation (SVV). The researchers concluded that “PVi and SVV are equally effective for guiding intraoperative goal-directed......

March 7, 2023

Morocco opens first lab for cannabis use in industry, medicine

Morocco, on Monday, inaugurated the country's first laboratory for medical and industrial use of cannabis, Anadolu News Agency reports.

In a statement, the Cooperative Bio Cannat said the lab in the north-western"...

February 23, 2023

Hikma delivers a resilient underlying performance in 2022

Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its preliminary audited results for the year ended 31 December 2022. In 2022, the Group reported revenue of $2.517 billion (slightly down from $2.553 billion in"...

February 23, 2023

Ferrer Acquires Worldwide Rights to ASN90, an O-GlcNAcase Inhibitor From Asceneuron, Exclusively to Treat Progressive Supranuclear Palsy (PSP)

Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron announce the signing of a licensing agreement in which Ferrer obtains the exclusive worldwide rights to develop and commercialize ASN90 in progressive supranuclear palsy (PSP), an orphan, tau-related"...

February 23, 2023

LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits

LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils a suite of LeviSelect™ cell depletion and enrichment kits for immunology research.LeviSelect Kits are a targeted expansion of the revolutionary"...